Age-modulated association between prefrontal NAA and the BDNF gene

International Journal of Neuropsychopharmacology

Volumn 16, Issue 6, 2013, Pages 1185-1193

  Salehi, Basira ^a   Preuss, Nora ^a   Van Der Veen, Jan Willem ^b   Shen, Jun ^b   Neumeister, Alexander ^c   Drevets, Wayne C ^b,d   Hodgkinson, Colin ^e   Goldman, David ^e   Wendland, Jens R ^b   Singleton, Andrew ^f   Gibbs, Jesse R ^f   Cookson, Mark R ^f   Hasler, Gregor ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d University of Oklahoma Tulsa College of Medicine   (United States)

^e NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^f NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

BDNF; genetic variation; N acetyl aspartate; proton magnetic resonance spectroscopy; SNP

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; N ACETYLASPARTIC ACID;

ADULT; AGING; ALLELE; ARTICLE; ASIAN; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR DEPRESSION; MALE; MOLECULAR INTERACTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGING; ASPARTIC ACID; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; RNA, MESSENGER; YOUNG ADULT;

EID: 84878825649     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145712001204     Document Type: Article

References (55)

1. Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp BD (2002). N-acetylaspartate is an axon-specific marker of mature white matter in vivo : A biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol 51:51-58.
2. Botteron KN, Raichle ME, Heath AC, Price A, Sternhell KE, Singer TM, Todd RD (1999). An epidemiological twin study of prefrontal neuromorphometry in early onset depression. Biol Psychiatry 45:59S.
3. Brooks JCW, Roberts N, Kemp GJ, Gosney MA, Lye M, Whitehouse GH (2001). A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cereb Cortex 11:598-605.
4. Charlton RA, McIntyre DJO, Howe FA, Morris RG, Markus HS (2007). The relationship between white matter brain metabolites and cognition in normal aging: The GENIE study. Brain Res 1164:108-116.
5. Connor B, Young D, Yan Q, Faull RL, Synek M (1997). Brainderived neurotrophic factor is reduced in Alzheimer's disease. Mol Brain Res 49:1513-1521.
6. Coyle JT, Duman RS (2003). Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38:157-160.
7. Drevets WC, Price JL, Simpson Jr. JR, Todd RD, et al. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386:824-827.
8. Duman RS, Heninger GR, Nestler EJ (1997). A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606.
9. Durany N, Michel T, Kurt J, Cruz-Sanchez FF, et al. (2000). Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains. Int J Dev Neurosci 18:807-813.
10. Egan MF, Kojima M, Callicott JH, Goldberg TE, et al. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257-269.
11. Falush D, Stephens M, Pritchard JK (2003). Inference of population structure using multilocus genotype data: Linked loci and correlated allele frequencies. Genetics 164:1567-1587.
12. First MB, Spitzer RL, Gibbon M, Williams JBW (2002). Structured clinical interview for DSM-IV-TR axis I disorders, research version, Patient Edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute.
13. Frodl TS, Koutsouleris N, Bottlender R, Born C, et al. (2008). Depression-related variation in brain morphology over 3 years : Effects of stress? Arch Gen Psychiatry 65:1156-1165.
14. Gallinat J, Schubert F, Bruhl R, Hellweg R, et al. (2010). Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex. Neuroimage 49:767-771.
15. Gibbs JR, van der Brug MP, Hernandez DG, Traynor BJ, et al. (2010). Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet 6 :e1000952.
16. Gruber S, Pinker K, Riederer F, Chmelík M, et al. (2008). Metabolic changes in the normal ageing brain : Consistent findings from short and long echo time proton spectroscopy. Eur J Radiol 68:320-327.
17. Haga KK, Khor YP, Farrall A, Wardlaw JM (2009). A systematic review of brain metabolite changes, measured with (1)H magnetic resonance spectroscopy, in healthy aging. Neurobiol Aging 30:353-363.
18. Hasler G (2010). Pathophysiology of depression: Do we have any solid evidence of interest to clinicians? World Psychiatry 9 :155-161.
19. Hasler G, Neumeister A, van der Veen JW, Tumonis T, et al. (2005). Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy. Biol Psychiatry 58:969-973.
20. Hasler G, van der Veen JW, Grillon C, Drevets W, et al. (2010a). Effect of acute psychological stress on prefrontal gamma-aminobutyric acid concentration determined by proton magnetic resonance spectroscopy. Am J Psychiatry 167:1226-1231.
21. Hasler G, van der Veen JW, Grillon C, Drevets WC, et al. (2010b). Effect of acute psychological stress on prefrontal GABA concentration determined by proton magnetic resonance spectroscopy. Am J Psychiatry 167:1226-1231.
22. Hasler G, van der Veen JW, Tumonis T, Meyers N, et al. (2007). Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64:193-200.
23. Hayes AF, Matthes J (2009). Computational procedures for probing interactions in OLS and logistic regression: SPSS and SAS implementations. Behav Res Methods 41:924-936.
24. Hirayasu Y, Shenton ME, Salisbury DF, Kwon JS, et al. (1999). Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 156:1091-1093.
25. Hodgkinson CA, Yuan QP, Xu K, Shen PH, et al. (2008). Addictions biology: Haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 43:505-515.
26. Huang EJ, Reichardt LF (2001). Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci 24:677-736.
27. Johnson PO, Fay LC (1950). The Johnson-Neyman technique and its theory and application. Psychometrika 15:349-367.
28. Johnson PO, Neyman J (1936). Tests of certain linear hypotheses and their application to some educational problems. Statist Res Mem 1:57-93.
29. Jung RE, Yeo RA, Chiulli SJ, Sibbitt WL, et al. (1999). Biochemical markers of cognition : A proton MR spectroscopy study of normal human brain. Neuroreport 10:3327-3331.
30. Karege F, Perret G, Bondolfi G, Schwald M, et al. (2002). Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109:143-148.
31. Krueger F, Pardini M, Huey ED, Raymont V, et al. (2011). The role of the Met66 brain-derived neurotrophic factor allele in the recovery of executive functioning after combat-related traumatic brain injury. J Neurosci 31:598-606.
32. Lang UE, Hellweg R, Seifert F, Schubert F, et al. (2007). Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity. Biol Psychiatry 62:530-535.
33. Liu LX, Foroud T, Xuei XL, Berrettini W, et al. (2008). Evidence of association between brain-derived neurotrophic factor gene and bipolar disorder. Psychiatr Genet 18:267-274.
34. Martinowich K, Manji H, Lu B (2007). New insights into BDNF function in depression and anxiety. Nat Neurosci 10:1089-1093.
35. Mattson MP, Maudsley S, Martin B (2004). BDNF and 5-HT: a dynamic duo in age-related neural plasticity and neurodegenerative disorders. Trends Neurosci 27:589-594.
36. Molina V, Sánchez J, Sanz J, Reig S, et al. (2007). Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder. Eur Psychiatry 22:505-512.
37. Narisawa-Saito M, Wakabayashi K, Tsuji S, Takahashi H, et al. (1996). Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. NeuroReport 7 :2925-2928.
38. Nestler EJ, Gould E, Manji H (2002). Preclinical models: Status of basic research in depression. Biol Psychiatry 52:503-528.
39. Olvera RL, Caetano SC, Fonseca M, Nicoletti M, et al. (2007). Low levels of N-acetyl aspartate in the left dorsolateral prefrontal cortex of pediatric bipolar patients. J Child Adolesc Psychopharmacol 17:461-473.
40. Olvera RL, Caetano SC, Stanley JA, Chen H-H, et al. (2010). Reduced medial prefrontal N-Acetyl-Aspartate levels in pediatric major depressive disorder : A multi-voxel in vivo1H spectroscopy study. Psychiatry Res: Neuroimaging 184:71-76.
41. Phillips HS, Hains JM, Armanini M, Laramee GR, et al. (1991). BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7 :695-702.
42. Potthoff RF (1964). On the Johnson-Neyman technique and some extensions thereof. Psychometrika 29:241-256.
43. Rostami E, Krueger R, Zoubak S, Dal Monte O, et al. (2011). BDNF polymorphism predicts general intelligence after penetrating traumatic brain injury. PLoS ONE. Published online 8 November 2011. doi :10.1371/journal.pone. 00273899
44. Sanacora G, Mason GF, Rothman DL, Hyder F, et al. (2003). Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 160:577-579.
45. Savitz J, Drevets WC (2009). Bipolar and major depressive disorder : Neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev 33:699-771.
46. Schinder AF, Poo M-m (2000). The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci 23:639-645.
47. Schuff N, Amend D, Ezekiel F et al. (1997). Changes of hippocampal N-acetyl spartate and volume in Alzheimer's disease. A proton MR spectroscopy imaging and MRI study. Neurology 49:1513-1521.
48. Schuff N, Amend DL, Knowlton R, Norman D, et al. (1999). Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging. Neurobiol Aging 20:279-285.
49. Sheline YI, Gado MH, Kraemer HC (2003). Untreated depression and hippocampal volume loss. Am J Psychiatry 160:1516-1518.
50. Shen J, Rothman DL, Brown P (2002). In vivo GABA editing using a novel doubly selective multiple quantum filter. Magn Reson Med 47:447-454.
51. Takahashi M, Shirakawa O, Toyooka K, Kitamura N, et al. (2000). Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol Psychiatry 5 :293-300.
52. Thompson M, Weickert CS, Wyatt E, Webster MJ (2011). Decreased BDNF, trkB-TK+ and GAD(67) mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci 36:195-203.
53. Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, et al. (2000). Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 47:475-481.
54. Wyss M, Kaddurah-Daouk R (2000). Creatine and creatinine metabolism. Physiol Rev 80:1107-1213.
55. Zhou N, Wang L (2008). Perfect population classification on Hapmap data with a small number of SNPs. In : Neural information processing : Part II (Ishikawa M, Doya K, Miyamoto H, Yamakawa T, eds), pp 789-797. Berlin : Springer-Verlag.